What is the recommended dose of cefotaxime for a 3-year-old boy weighing 13 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefotaxime Dosing for a 13 kg, 3-Year-Old Boy

The recommended dose of cefotaxime for a 3-year-old boy weighing 13 kg is 150 mg/kg/day divided into 3 doses (650 mg IV every 8 hours).

Dosing Calculation

For a 13 kg child:

  • Standard pediatric dosage: 150 mg/kg/day 1
  • Total daily dose: 13 kg × 150 mg/kg = 1,950 mg/day
  • Divided into 3 doses (every 8 hours): 650 mg per dose

Rationale for Dosing

The recommended dosage is based on the following considerations:

  1. Age and weight appropriateness: For infants and children (1 month to 12 years) weighing less than 50 kg, the FDA-approved dosage range is 50-180 mg/kg/day divided into 4-6 doses 2.

  2. Infection severity: The higher end of the dosing range (150 mg/kg/day) is recommended for more severe infections, including meningitis 2. This dosage ensures adequate coverage for most common pathogens.

  3. Dosing frequency: While the FDA label suggests dividing into 4-6 doses, clinical guidelines support an 8-hour dosing interval (3 times daily) for cefotaxime in pediatric patients 1.

Alternative Dosing Considerations

  • Some recent research suggests that higher doses (up to 200 mg/kg/day) may be needed for critically ill children to achieve adequate exposure for less susceptible pathogens 3.

  • While some studies have evaluated twice-daily dosing (100 mg/kg/day divided into 2 doses) for lower respiratory tract infections 4, the standard three-times-daily regimen remains preferred for most indications to maintain consistent antimicrobial coverage.

Important Clinical Considerations

  • Duration of therapy: Continue cefotaxime for at least 48-72 hours after the patient defervesces or after evidence of bacterial eradication 2.

  • Monitoring: No routine therapeutic drug monitoring is required for cefotaxime, but renal function should be monitored in patients with known or suspected renal impairment.

  • Common side effects: Gastrointestinal disturbances, rash, and transient elevations in liver enzymes.

  • Potential pitfall: Underdosing cefotaxime can lead to treatment failure, especially for less susceptible organisms. Always use the appropriate weight-based dose rather than estimating.

By following this dosing regimen, adequate antimicrobial coverage should be achieved while minimizing the risk of adverse effects in this pediatric patient.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.